It does seem that Don is always dealing from a position of weakness rather than leveraging the multiple BPs that zen3694 could impact in terms of lengthening their drugs effectiveness.

I'm not sniffing any hint of liquidity either. We'll see what Thursday brings but not holding my breath for any short term value creation for shareholders.

Has Newsoara given up patent rights for the regions?

Toinv